NCT02098200View on ClinicalTrials.gov

Percutaneous Treatment of Tricuspid Valve Regurgitation With the TriCinch System™

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

November 30, 2016

Study Completion Date

October 31, 2017

Conditions
Tricuspid Regurgitation
Interventions
DEVICE

TriCinch System

Percutaneous treatment of Tricuspid Regurgitation

Trial Locations (14)

20121

Monzino Hospital, Milan

20129

San Raffaele Hospital, Milan

31076

Clinique Pasteur, Toulouse

35128

Azienda Ospedaliera di Padova, Padua

53127

Universitatsklinikum Bonn, Bonn

54100

Fondazione Toscana G. Monasterio Ospedale del Cuore G. Pasquinucci, Massa

56124

University Hospital Pisa, Pisa

60389

CardioVasculares Centrum Frankfurt, Frankfurt am Main

75877

Bichat Hospital, Paris

95124

Ferrarotto Hospital, Catania

Unknown

Hospices Civils de Lyon, Lyon

UKE Heart Center, Hamburg

Fondazione PTV Policlinico Tor Vergata, Roma

3430EM

St. Antonius Ziekenhuis, Nieuwegein

All Listed Sponsors
lead

4Tech Cardio Ltd.

INDUSTRY

NCT02098200 - Percutaneous Treatment of Tricuspid Valve Regurgitation With the TriCinch System™ | Biotech Hunter | Biotech Hunter